THE COST-EFFECTIVENESS OF TELAPREVIR TRIPLE THERAPY IN TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS IN TURKEY

被引：0
|
作者：
Ozdemir, O. [1 ]
机构：
[1] Yorum Consultancy, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN36
引用
收藏
页码：A670 / A670
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [2] Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C
    Brogan, Anita J.
    Talbird, Sandra E.
    Thompson, James R.
    Miller, Jeffrey D.
    Rubin, Jaime
    Deniz, Baris
    [J]. PLOS ONE, 2014, 9 (03):
  • [3] Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies
    Buti, Maria
    Gros, Blanca
    Oyagueez, Itziar
    Andrade, Raul J.
    Angel Serra, Miguel
    Turnes, Juan
    Casado, Miguel A.
    [J]. HEPATOLOGY, 2013, 58 : 1133A - 1133A
  • [4] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [5] Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
    Blazquez-Perez, Antonio
    San Miguel, Ramon
    Mar, Javier
    [J]. PHARMACOECONOMICS, 2013, 31 (10) : 919 - 931
  • [6] Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
    Antonio Blázquez-Pérez
    Ramón San Miguel
    Javier Mar
    [J]. PharmacoEconomics, 2013, 31 : 919 - 931
  • [7] COST-EFFECTIVENESS OF SIMEPREVIR VS. TELAPREVIR FOR THE TRIPLE THERAPY OF HEPATITIS C IN KAZAKHSTAN
    Bektur, C.
    Nurgozhin, T.
    Abdukhakimova, D.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A627 - A627
  • [8] COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
    Kaczor, M. P.
    Wojcik, R.
    Pawlik, D.
    Skrzekowska-Baran, I
    Tronczynski, K.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A359 - A360
  • [9] Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
    Camma, Calogero
    Petta, Salvatore
    Enea, Marco
    Bruno, Raffaele
    Bronte, Fabrizio
    Capursi, Vincenza
    Cicchetti, Americo
    Colombo, Giorgio L.
    Di Marco, Vito
    Gasbarrini, Antonio
    Craxi, Antonio
    [J]. HEPATOLOGY, 2012, 56 (03) : 850 - 860
  • [10] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
12345